(URAN) Themes Uranium & Nuclear - Overview
Etf: Uranium Mining, Nuclear Utilities, Fuel Cycle, Reactor Construction
Dividends
| Dividend Yield | 2.62% |
| Yield on Cost 5y | 3.97% |
| Yield CAGR 5y | 999.90% |
| Payout Consistency | 83.3% |
| Payout Ratio | - |
| Risk 5d forecast | |
|---|---|
| Volatility | 49.2% |
| Relative Tail Risk | -8.52% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.14 |
| Alpha | 33.51 |
| Character TTM | |
|---|---|
| Beta | 0.963 |
| Beta Downside | 0.691 |
| Drawdowns 3y | |
|---|---|
| Max DD | 31.96% |
| CAGR/Max DD | 1.57 |
Description: URAN Themes Uranium & Nuclear January 07, 2026
The Themes Uranium & Nuclear ETF (BATS: URAN) tracks an index of companies that generate a material portion of their revenue from uranium mining, nuclear fuel production, and related services. In normal conditions, the fund allocates at least 80% of its net assets-plus any borrowing capacity-to the index constituents, including their ADRs and GDRs, and is classified as a non-diversified vehicle, implying higher concentration risk.
Key sector drivers include the spot price of uranium, which rose to roughly $55 lb⁻¹ in early 2024 after a multi-year rally, and the global push to expand nuclear capacity-China alone plans to add over 30 GW of reactors by 2035, boosting demand for fuel and services. Supply constraints from major producers such as Kazatomprom and Cameco also tighten the market, supporting higher margins for the ETF’s holdings. A useful KPI to monitor is the “Uranium Production Cost Curve,” which shows the proportion of producers operating below $30 lb⁻¹, a threshold often linked to profitability spikes.
If you want granular, up-to-date analytics on URAN’s exposure and valuation metrics, consider exploring ValueRay for a deeper dive.
What is the price of URAN shares?
Over the past week, the price has changed by -6.26%, over one month by +0.46%, over three months by +6.58% and over the past year by +50.83%.
Is URAN a buy, sell or hold?
What are the forecasts/targets for the URAN price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 66.7 | 43.3% |
URAN Fundamental Data Overview February 04, 2026
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 30.4m USD (30.4m + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
EV/FCF = unknown (FCF TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 30.4m)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 30.4m / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default 21%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 21.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 9.46% (E(30.4m)/V(30.4m) * Re(9.46%) + (debt-free company))
Discount Rate = 9.46% (= CAPM, Blume Beta Adj.)
Fair Price DCF = unknown (Cash Flow 0.0)